RUA Life Sciences Submits FDA Application for Vascular Grafts
03 Noviembre 2021 - 3:48AM
Noticias Dow Jones
By Sabela Ojea
RUA Life Sciences PLC said Wednesday that the RUA Vascular
business has submitted its premarket notification for a range of
polymerically sealed vascular grafts to the U.S. Food and Drug
Administration.
The developer of polymer materials for medical devices said the
submission follows an introduction of the RUA graft at the recent
annual meeting of the European Association for Cardio-Thoracic
Surgery, held in Barcelona, Spain.
Shares at 0912 GMT were up 10.00 pence, or 6.6%, at 161.50
pence.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
November 03, 2021 05:33 ET (09:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
